Document Detail


Protein Z in patients with pregnancy complications.
MedLine Citation:
PMID:  16260213     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: This study was undertaken to evaluate the association between protein Z concentration and pregnancy complications. STUDY DESIGN: A prospective case-control study was conducted over a 2-year period to evaluate the prevalence of protein Z deficiency in pregnancy complications. Protein Z levels were measured at the time of diagnosis of complications such as preeclampsia, intrauterine growth restriction, and intrauterine fetal demise. Protein Z deficiency was defined as a plasma level below 1.2 mg/L. In addition to patients presenting with pregnancy complications, healthy age-matched nonpregnant and pregnant women were invited to participate. RESULTS: A total of 145 women were included in the study: 50 nonpregnant women, 34 healthy pregnant women, 29 women with preeclampsia, 25 women presented with intrauterine growth restriction, and 7 women with intrauterine fetal demise. The median protein Z level was similar in healthy pregnant and nonpregnant women (1.63 [0.47-3.1] mg/L and 1.69 [0.7-3] mg/L, respectively). Three women with normal pregnancies had a low protein Z level (8.8%), compared with 8 patients presenting with intrauterine growth restriction (33.3%) and 8 patients with intrauterine fetal demise (50%). Compared with normal pregnancy, the frequency of decreased protein Z was significantly higher in cases of intrauterine growth restriction and in intrauterine fetal demise (relative risk [RR] 1.96, 95% CI 1.16-3.32; P = .041 and RR 3.36, 95% CI 1.65-6.8; P = .0031, respectively), but not in preeclampsia (RR 1.6, 95% CI 0.9-2.8; P = .23). Placenta histologic examination revealed vascular lesions in 50% of patients with protein Z deficiency and in 33% of patients with normal levels of protein Z (RR 0.84; 95% CI 0.6-1.2). CONCLUSION: Protein Z deficiency is associated with late fetal demise and intrauterine growth restriction. The pathophysiologic role of protein Z deficiency, either congenital or caused by the presence of specific antibodies remains unclear and should be further investigated.
Authors:
Florence Bretelle; Dominique Arnoux; Raha Shojai; Claude D'Ercole; José Sampol; Françoise Dignat; Laurence Camoin-Jau
Related Documents :
24554373 - Drug treatment of hypertension in pregnancy.
11311763 - Use of omeprazole during pregnancy--no hazard demonstrated in 955 infants exposed durin...
21366123 - Maternal and neonatal morbidity among nulliparous women undergoing elective induction o...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  193     ISSN:  1097-6868     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  2005 Nov 
Date Detail:
Created Date:  2005-11-01     Completed Date:  2006-01-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1698-702     Citation Subset:  AIM; IM    
Affiliation:
Service de Gynécologie-Obstétrique, Pr. B. Blanc, Centre Hospitalo-Universitaire de la Conception, 13385 Marseille Cedex, France. florence.bretelle@mail.ap-hm.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Proteins / deficiency*
Case-Control Studies
Female
Humans
Pregnancy
Pregnancy Complications / epidemiology*
Prevalence
Prospective Studies
Protein Deficiency / complications,  epidemiology*
Chemical
Reg. No./Substance:
0/Blood Proteins; 0/plasma protein Z

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Maternal plasma concentrations of IGF-1, IGFBP-1, and C-peptide in early pregnancy and subsequent ri...
Next Document:  A free radical scavenger, edaravone, inhibits lipid peroxidation and the production of nitric oxide ...